Ismael A. Vergara
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Sites of metastases before systemic treatment influence progression patterns and survival in stage IV melanoma patients.
Journal: Immuno-oncology technology
Published: November 24, 2025
Pathological response calculation assessment remains accurate with reduced tumor bed examination after neoadjuvant immunotherapy in clinically detectable stage III melanoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 05, 2025
DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance.
Journal: JCO precision oncology
Published: November 07, 2024
Evaluation of clonality in lentigo maligna.
Journal: The Journal of investigative dermatology
Published: August 12, 2024
Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma.
Journal: Nature medicine
Published: July 24, 2024
Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 19, 2024
Weakly supervised deep learning image analysis can differentiate melanoma from naevi on haematoxylin and eosin-stained histopathology slides.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: May 31, 2024
Prognostic Significance of Incipient Ulceration in Primary Cutaneous Melanoma.
Journal: JAMA dermatology
Published: November 01, 2023
Seasonal patterns of toxicity in melanoma patients treated with combination anti-PD-1 and anti-CTLA-4 immunotherapy.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 11, 2023
Last Updated: 09/26/2026